The following points should be discussed to simplify the BPR, while aiming to reduce the growing inequality between active substancesa result of delays in the Review Program and the introduction of new regulatory requirements: (1) Require MSCA to prioritize the assessment of Active Substance (AS) dossiers that have never been evaluated.
LP
Laboratoire PAREVA
Company · France
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Laboratoire in PolicySpeak: request access →
Work at Laboratoire PAREVA? so we know who speaks for it.
Their record over time
Laboratoire PAREVA filed 2 positions on 5 Mar 2026, across 1 of the 665 legislative files tracked here.
What they argued
Our proposal to simplify the BPR: – A single dossier only per biocidal Active Substance, regardless of the number of intended product types (pts) to be supported – Composition of such dossier: Only Part A is required (meeting the requirements of Annex II of the BPR). – Uniform application: The same rule applies to both new active substances and existing ones (under the Review Programme).
Filed in French · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Laboratoire PAREVA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Laboratoire PAREVA’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.